WO2025219956 - COMPOSITIONS AND METHODS FOR RNA DELIVERY TO CELLS

National phase entry is expected:
Publication Number WO/2025/219956
Publication Date 23.10.2025
International Application No. PCT/IB2025/054089
International Filing Date 18.04.2025
Title **
[English] COMPOSITIONS AND METHODS FOR RNA DELIVERY TO CELLS
[French] COMPOSITIONS ET PROCÉDÉS POUR UNE ADMINISTRATION D'ARN À DES CELLULES
Applicants **
COMED THERAPEUTICS LTD.
Inventors
ÖZTÜRK, Cenk
HEKIM, Suleyman Nezih
Priority Data
63/635,707   18.04.2024   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3481
EPO Filing, Examination, Granting26996
Japan Filing, Examination, Granting3173
South Korea Filing, Examination, Granting4146
USA Filing, Examination, Granting11990
MasterCard Visa
Total: 49,786
Contact Us
Abstract[English] Provided are molecular hooks that are capable of tethering a ribonucleic acid (RNA) of interest to a high-density lipoprotein (HDL) molecule. Also provided are methods of RNA delivery to cells and organisms using the molecular hooks of the present disclosure. Such methods provide several advantages including the ability to deliver the RNA of interest to tissues behind the blood-brain barrier, and not requiring extreme cold temperatures for storage or transport.[French] L'invention concerne des crochets moléculaires qui sont capables de fixer un acide ribonucléique (ARN) d'intérêt à une molécule de lipoprotéine haute densité (HDL). L'invention concerne également des procédés d'administration d'ARN à des cellules et des organismes utilisant des crochets moléculaires de la présente invention. De tels procédés fournissent plusieurs avantages comprenant la capacité d'administrer l'ARN d'intérêt à des tissus derrière la barrière hémato-encéphalique, et ne nécessitant pas de températures froides extrêmes pour le stockage ou le transport.